Erin VanDyke Congratulates IU Health on Joining the NBCA COE Program
Erin VanDyke, PA-C, MPAS, Vice President of National Blood Clot Alliance Centers of Excellence, reposted from NBCA on LinkedIn:
”Congrats to the VTE teams at IU Health and welcome to the National Blood Clot Alliance COE program!!
We are so excited for this partnership and for the VTE excellence this team brings to Indiana.
Great things happen when patients, clinicians, and community come together!
Looking forward to the path forward..together!!
NBCA posted on LinkedIn:
”Great news for blood clot patients in Indiana!
The National Blood Clot Alliance (NBCA) is proud to announce IU Health Methodist Hospital in Indianapolis as the state’s first NBCA Venous Thromboembolism (VTE) Center of Excellence™, joining a growing national network dedicated to excellence in the prevention, diagnosis, and treatment of blood clots.
This recognition reflects the outstanding multidisciplinary efforts across IU Health, including teams at both Methodist and University hospitals. Their collaboration has been instrumental in achieving the high standards required for this designation. As IU Health prepares to integrate these hospitals into a single, state-of-the-art facility, this designation will carry forward — underscoring a continued commitment to excellence in VTE care.
‘This designation reflects our team’s tireless efforts to implement timely diagnosis, appropriate treatment, and long-term prevention strategies for patients at risk of blood clots,’ said Paul Haste, MD. ‘We could not be more excited to partner with NBCA to continue this important work improving care for patients throughout the state of Indiana.’
Congratulations to IU Health Methodist Hospital for this well-deserved honor.”
Stay updated on the latest news in the field of hematology with Hemostasis Today.
-
Nov 3, 2025, 08:23The 1st Participant in A New CHECK-NIRS Clinical Study is Enrolled!
-
Nov 3, 2025, 08:15Bert van Meurs Shares the New Late-breaking Results from the iMODERN Trial
-
Nov 3, 2025, 07:10Lisa Shea Shares Key Takeaways from NORD Summit 2025
-
Nov 3, 2025, 06:49Darshan Doshi on Results of iMODERN and ILIAS ANOCA Studies Presented at TCT 2025
-
Nov 2, 2025, 14:172019 ESC/EAS Guidelines for the Management of Dyslipidaemias Discussion with Lale Tokgözoğlu and Jeanine Roeters van Lennep
-
Nov 3, 2025, 09:13Claudio Carrubba on How Timing Truly Matters in Trauma Embolization
-
Nov 3, 2025, 08:46Rachel Lamerton and Colleagues on Activation of Platelets in Flow Cytometry
-
Nov 3, 2025, 04:56Nirupama Ramadas and Erica Sparkenbaugh on Thromboinflammation in SCD
-
Nov 2, 2025, 14:21Claude Franceschi: I Advise You to Understand the Hemodynamic Pathophysiology of Venous Diseases Rather than Blindly Applying Ablation Techniques or Venous Stent Placement
-
Nov 2, 2025, 14:15Krishna Aragam: Why are (DCM) and Heart Failure About Twice as Common in Individuals of Self-Identified Black Race?
-
Oct 29, 2025, 07:31The Use of Artificial Intelligence to Improve Detection of Acute Incidental Pulmonary Emboli - JTH
-
Oct 29, 2025, 07:05Shrinidhi Nathany: AI in Diagnostic Medicine
-
Oct 28, 2025, 07:02Aya Berman: AI Model for Predicting Bacteremia
-
Oct 28, 2025, 06:55The New Era of Genomics, AI and Cell Therapy in Hematology and Infectious Diseases
-
Oct 28, 2025, 06:49Lukas Gaats: Researchers Are Building Reproductive Organoids
-
Nov 3, 2025, 09:24Stephen Cornelissen: It’s Not Just About Emergencies — It’s About Everyday Care, Chronic Conditions and Hope
-
Nov 3, 2025, 06:57Maria Elisa Mancuso Reflects on 2025 Annual Congress of the Italian Association of Hemophilia Centres
-
Nov 3, 2025, 05:46Chandra Viswanathan: When Blood Safety Fails, We All Bleed - A Call for Reform and Responsibility
-
Nov 2, 2025, 14:17Anamaria B: Your Mother Still Runs Part of Your DNA
-
Nov 2, 2025, 10:57Paul Bolaji on Launching The First Centralised Nigerian National Stroke Registry